Related Experiment Video
Updated: Jun 16, 2026

Efficient and Scalable Directed Differentiation of Clinically Compatible Corneal Limbal Epithelial Stem Cells from Human Pluripotent Stem Cells
Published on: October 24, 2018
Stem cell therapies for ocular surface disease
Sajjad Ahmad1, Sai Kolli, Majlinda Lako
1North East England Stem Cell Institute, Central Parkway, Newcastle upon Tyne NE13BZ, UK.
Abstract:
Transparency of the cornea on the front surface of the eye is essential for vision. A variety of blinding ocular surface diseases involve the cornea. This review focusses on vision loss caused by disruption of the integrity and function of the outermost corneal layer (the epithelium) and the stem-cell-based therapeutic strategies in use and under development to restore sight in affected patients.
Related Concept Videos
iPS Cell Differentiation
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Clinical Applications of Epidermal Stem Cells
Induced Pluripotent Stem Cells
Induced Pluripotent Stem Cells
Somatic cells are...
Stem Cell Culture

